| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPGI.00391.2016 |
| P698 | PubMed publication ID | 28007748 |
| P2093 | author name string | Stephen J Vanner | |
| David E Reed | |||
| P2860 | cites work | Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. | Q50687545 |
| Fundamentals of Neurogastroenterology: Basic Science. | Q50965155 | ||
| Neuronal activation by mucosal biopsy supernatants from irritable bowel syndrome patients is linked to visceral sensitivity. | Q53839188 | ||
| Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome | Q56996391 | ||
| Role for protease activity in visceral pain in irritable bowel syndrome | Q22241892 | ||
| Gut microbiota as potential orchestrators of irritable bowel syndrome | Q28085584 | ||
| Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis | Q28244815 | ||
| Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling | Q28481171 | ||
| Interplay between mast cells, enterochromaffin cells, and sensory signaling in the aging human bowel | Q28822420 | ||
| Bacterial cell products signal to mouse colonic nociceptive dorsal root ganglia neurons | Q33615704 | ||
| Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate | Q34365070 | ||
| The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota | Q34596449 | ||
| Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice | Q35761007 | ||
| Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome | Q35817564 | ||
| Inflammation-induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage-gated ion channels | Q36089198 | ||
| P2Y Receptors Sensitize Mouse and Human Colonic Nociceptors | Q36610295 | ||
| Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain | Q36930795 | ||
| TRP channels: new targets for visceral pain | Q37653083 | ||
| Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome | Q37871421 | ||
| The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis | Q37951770 | ||
| Extrinsic primary afferent signalling in the gut. | Q38084452 | ||
| Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? | Q38104610 | ||
| Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation. | Q38121999 | ||
| Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome | Q38193901 | ||
| Ex vivo study of human visceral nociceptors | Q38818922 | ||
| Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome | Q38912595 | ||
| Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome | Q39178305 | ||
| The Intestinal Microenvironment and Functional Gastrointestinal Disorders | Q39795816 | ||
| Human visceral afferent recordings: preliminary report. | Q39823047 | ||
| α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors. | Q41160258 | ||
| Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes | Q42509169 | ||
| Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity? | Q43420598 | ||
| Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. | Q45189883 | ||
| Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. | Q47746673 | ||
| The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. | Q48124178 | ||
| Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients | Q48636355 | ||
| Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome | Q48841933 | ||
| Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome. | Q50560274 | ||
| P433 | issue | 3 | |
| P304 | page(s) | G201-G207 | |
| P577 | publication date | 2016-12-22 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Emerging studies of human visceral nociceptors | |
| P478 | volume | 312 |
| Q92982366 | Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study | cites work | P2860 |
Search more.